Microrna-148a-3p Reduces Inflammatory Response By Inhibiting Irs-1 And Ldlr In Diabetic Foot Ulceration

Junfang Yi,Wenjiang Pan,Xiaoqiang Li
2021-01-01
Abstract:Objective: This study aimed to investigate the serum expression levels of MicroRNA-148a-3p, IRS-1 and LDLR in patients with diabetic foot (DF) and their relationship with inflammatory response. Methods: Forty-two patients with DF admitted to our hospital were enrolled as the study group. 43 diabetic patients without DF were enrolled as the disease control group, and 58 healthy individuals were selected as the healthy control group. The levels of MicroRNA-148a-3p, IRS-1 and LDLR expression in the serum of all participants were detected, and correlation analysis was performed between the serum levels and the clinical parameters, grades of severity for DF and inflammatory response. Results: The expression levels of MicroRNA-148a-3p, IRS-1 and LDLR in the study group, disease control group and healthy control group were statistically significant (P<0.05). The serum levels of MicroRNA-148a-3p were lower, and IRS-1 and LDLR were higher in patients with DF who developed inflammatory response than those in patients without DF (P<0.05). As the DF worsened, the serum level of MicroRNA-148a-3p gradually decreased, and the levels of IRS-1 and LDLR gradually increased (P<0.05). Conclusion: MicroRNA-148a-3p showed low expression in the serum of patients with DF who developed inflammatory reactions, and it was clinically possible to inhibit IRS-1 and LDLR by increasing the expression level of MicroRNA-148a-3p, so as to reduce inflammatory reactions in patients with DF.
What problem does this paper attempt to address?